National Medical Products Administration (NMPA) has approved the marketing of Cogriptin Tablets.

📩 info@dengyuemed.com
🔗 dengyuemed.com

#Cogriptin #Beichangping #HisunPharma #Type2Diabetes #DPP4Inhibitor #GLP1 #GIP #NMPA #ChinaPharma #InnovativeDrug #DiabetesTreatment #BloodGlucoseControl

恭賀我們的合作夥伴 深圳 #艾欣达伟医药科技有限公司：
授權 AST-3424（亦稱 OBI-3424）在中國大陸、香港及澳門的權益(研發、註冊、生產及商業化)予浙江 #海正藥業股份有限公司 (Zhejiang Hisun Pharmaceutical)
ascentawits.com/CompanyNews/...

#OBIPharma #Ascentawits #HisunPharma
#AST3424 #OBI3424